Blogs written by our own experts or selected members of the drug discovery community.
Thinking about biomarkers early in your drug discovery project and defining a clear biomarker strategy to address a range of clinical questions
The importance of clinical samples in R&D and how to access them
The importance of thinking about safety early in the drug discovery programme
A practical guide for the present and a look to the future at Sequani
Using complex cell models in early de-risking strategies and toxicity testing
The advantages and disadvantages of in vitro cell models using primary cells
Importance of understanding target engagement
The advantages and disadvantages of in vitro cell models using primary cells
Lessons for efficacy studies at AxisBio
See how we can help support you with your next drug discovery project.
Speak to us
